Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Adjuvanted Hepatitis B vaccine (Recombinant) - Dynavax Technologies

Drug Profile

Adjuvanted Hepatitis B vaccine (Recombinant) - Dynavax Technologies

Alternative Names: HBsAg-1018; HBV vaccine preventative - Dynavax; HBV-ISS preventative vaccine; Hepatitis B Vaccine (Recombinant), Adjuvanted; Hepatitis B vaccine 1018-ISS conjugate - Dynavax; Hepatitis B vaccine preventative - Dynavax; HEPLISAV; HEPLISAV-B; V270

Latest Information Update: 07 May 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Dynavax Technologies
  • Class Hepatitis B vaccines; Oligonucleotides; Synthetic vaccines
  • Mechanism of Action Immunostimulants; Toll-like receptor 9 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Marketed Hepatitis B

Most Recent Events

  • 30 Apr 2019 Dynavax Technologies initiates enrolment in a phase I pharmacokinetics trial in USA (NCT03934736)
  • 28 Mar 2019 European Medicines Agency accepts Marketing authorization application for Hepatitis B vaccine, recombinant, adjuvanted for Hepatitis B (Prevention) for review
  • 11 Mar 2019 Dynavax Technologies Corporation resubmits the MAA to EMA for Hepatitis B (Prevention) in European Union (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top